Upvote
Downvote
Key Account Manager at Amylyx Pharmaceutical
Share Job
- Suggest Revision
- Key Account Manager at Amylyx Pharmaceutical in Denver, CO
- Amylyx was started in 2013 by two Brown University undergraduates who proposed a proprietary combination of two known drugs to treat ALS. In the Fall of 2020, the successful results of their clinical trial were published in the New England Journal of Medicine.
- Submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for AMX0035 for the treatment of amyotrophic lateral sclerosis (ALS) Filed a New Drug Submission (NDS) for AMX0035 for the treatment of ALS with Health Canada Initiating a global Phase 3 clinical trial (Phoenix) with sites in Europe and the United States in the fourth quarter of 2021 100 FTEs and growing strong!
- With strong financial backing from Viking Global Investors, Bain Capital, Belinda Termeer, and Morningside Group and recent announcements to file for registration in the US and Canada, we are planning a global launch
- The Opportunity:As a Neurology Key Account Manager (KAM), you will represent Amylyx and AMX0035 for the treatment of approved indications for ALS and any future-approved indications.
Active Job
Updated YesterdaySimilar Job
Relevance
Active